Your session is about to expire
← Back to Search
Topoisomerase I inhibitors
Topotecan for Brain Cancer
Phase 1 & 2
Waitlist Available
Led By Jeffrey Bruce, MD
Research Sponsored by Jeffrey N. Bruce
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
This study will evaluate the safety and efficacy of a chemotherapeutic drug (topotecan) as it is given directly into brain tumors by a delivery technique called convection-enhanced delivery. This drug has been used for different types of cancer, but in this study it will be given by an experimental delivery technique designed to maximize the amount of drug delivered to the brain tumor and minimize the side effects in other parts of the body. This study will also evaluate advanced magnetic resonance (MR) imaging techniques. The study will assess quality of life parameters throughout the follow-up period.
Eligible Conditions
- Brain Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
1Treatment groups
Experimental Treatment
Group I: TopotecanExperimental Treatment2 Interventions
Once a plastic catheter is placed, within 24 hours of placement, the catheter will be connected to a small pump at the bedside, and the convection-enhanced delivery of the Topotecan will begin. The Topotecan will be infused for 4 to 5 days after which time the catheters will simply be pulled out. Patients will be monitored with blood tests and MRI scans during the treatment and at different time periods during the following months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Topotecan
FDA approved
Find a Location
Who is running the clinical trial?
Jeffrey N. BruceLead Sponsor
1 Previous Clinical Trials
5 Total Patients Enrolled
Jeffrey Bruce, MDPrincipal InvestigatorColumbia University
1 Previous Clinical Trials
5 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger